Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-31 @ 4:12 PM
Study NCT ID:
NCT01568294
Status:
COMPLETED
Last Update Posted:
2019-11-12
First Post:
2012-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Pomalidomide in Patients With Refractory or Relapsed and Refractory Multiple Myeloma
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2015-07-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-29
First Submit QC Date:
None
Study First Post Date:
2012-04-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-07
Last Update Post Date:
2019-11-12
Last Update Post Date Type:
ACTUAL